Latest Contracts News

Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.

Fortescue Metals Group has delivered its highest ever half-year iron ore shipments of 97.1 million tonnes, alongside a notable 10% reduction in hematite production costs, underscoring operational strength and advancing decarbonisation efforts.

InFocus Group Holdings reports $500,000 in cash receipts from the first phase of its VigoBet digital gaming platform contract, with the project nearing completion and promising further phases.

International Graphite Limited has locked in a $2 million government grant to fund critical feasibility studies for its Western Australian battery anode materials project, reinforcing its mine-to-market strategy.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.

Noble Helium Limited has postponed its western margin shallow drilling program due to adverse weather and restricted site access, aiming to resume once conditions improve.

RocketDNA has reported its strongest quarter yet, breaking the $2 million revenue barrier and marking its first international export of the xBot® autonomous drone platform to a major African mining operation.

SelfWealth Ltd reported a 4% revenue increase and sustained profitability in H1 2025, while advancing a major transformation program and entering a proposed acquisition deal with Bell Financial Group.

Cyclopharm has inked a pivotal three-year agreement with HCA Healthcare, enabling deployment of its Technegas® lung imaging technology across up to 169 US nuclear medicine departments. This deal marks a major step in expanding Technegas®’ footprint in the American healthcare market.

Icetana Limited reports a challenging December quarter with declining revenues but secures significant new contracts and launches a fully underwritten $2.65 million rights issue.

Icetana AI has launched a fully underwritten renounceable entitlement offer to raise approximately A$2.65 million, aiming to bolster sales, marketing, and product development. The company is also nearing a potential $1.77 million deal linked to its Baghdad Safe City project in Iraq.